《血液学杂志》.2004年.第4期

　

• A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis
• A novel SHP-1/Grb2–dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine
• A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation
• Allergen exposure–induced differences in CD34+ cell phenotype: relationship to eosinophilopoietic responses in different compartments
• And a final message from antithrombin
• Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells
• Antibody-induced intracellular signaling works in combination with radiation to eradicate lymphoma in radioimmunotherapy
• Anti-CD40L: biology and therapy in ITP
• Regulation of MHC class II expression in human T-cell malignancies
• Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients
• Signaling by ephrinB1 and Eph kinases in platelets promotes Rap1 activation platelet adhesion, and aggregation via effector pathways that do not requ
• Specific inhibition of HIV-1 coreceptor activity by synthetic peptides corresponding to the predicted extracellular loops of CCR5
• Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP
• Swinging for the fences: persistent and efficient liver-directed gene therapy for hemophilia A
• Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype
• Transfer of allogeneic CD62L– memory T cells without graft-versus-host disease
• BUBR1 deficiency results in abnormal megakaryopoiesis
• Cell adhesion: a partner for many
• Chemokine receptor–8(CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion
• Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation
• Coagulation inflammation, and apoptosis: different roles for protein S and the protein S–C4b binding protein complex
• CXCR4 engagement is required for HIV-1–induced L-selectin shedding
• Cyclophosphamide metabolism is affected by azole antifungals
• Deletion of the -globin gene cluster as a cause of acquired -thalassemia in myelodysplastic syndrome
• Dimerize and die
• Direct killing of Epstein-Barr virus(EBV)–infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1
• Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses
• Dual roles of the C-terminal Src kinase(Csk) during developmental vascularization
• Dynamic regulation of Src-family kinases by CD45 in B cells
• Early prediction of response in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic leukemia(Ph+ALL) treated w
• Endothelial progenitor cells in infantile hemangioma
• ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein
• Functional endothelial cells derived from rhesus monkey embryonic stem cells
• Fungal infection in hemato-oncologic patients: better to prevent than to treat?
• Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9
• HFE a putative hepatocyte iron sensor?
• Identification of the molecular requirements for an RAR-mediated cell cycle arrest during granulocytic differentiation
• In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation
• Ineffective hematopoiesis linked with a mitochondrial tRNA mutation(G3242A) in a patient with myelodysplastic syndrome
• Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants
• Platelet collagen receptors play molecular ping-pong
• Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with
• Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL
• High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation
• Identification and characterization of EBP a novel EEN binding protein that inhibits Ras signaling and is recruited into the nucleus by the MLL-EEN f
• Identification of a 4-base deletion in the gene in inherited intrinsic factor deficiency
• Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PET
• Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells
• Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia
• The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leu
• The myelodysplastic syndromes: heterogeneneity on many levels
• Thymosin 4 induces the synthesis of plasminogen activator inhibitor 1 in cultured endothelial cells and increases its extracellular expression
• Localization of iron metabolism–related mRNAs in rat liver indicate that HFE is expressed predominantly in hepatocytes
• LPAM(47 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease
• Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome
• Novel concatameric heparin-binding peptides reverse heparin and low-molecular-weight heparin anticoagulant activities in patient plasma in vitro and i
• Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model
• Eµ-BRD2 transgenic mice develop B-cell lymphoma and leukemia
• Fc-RIIIa and Fc-RIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia